$3.09 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 124 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 71.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ASPX | Buy | AUSPEX PHARMACEUTICALS INC | $446,112,000 | +188.2% | 4,449,103 | +50.9% | 14.45% | +159.9% |
HZNP | Buy | HORIZON PHARMA PLC | $332,226,000 | +120.3% | 12,792,689 | +9.3% | 10.76% | +98.6% |
Buy | ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0 | $98,882,000 | +672.8% | 100,750,000 | +675.0% | 3.20% | +596.3% | |
ABBV | New | ABBVIE INC | $89,800,000 | – | 1,534,000 | +100.0% | 2.91% | – |
NXTM | Buy | NXSTAGE MEDICAL INC | $87,764,000 | +1.7% | 5,073,050 | +5.4% | 2.84% | -8.3% |
ARRY | ARRAY BIOPHARMA INC | $87,221,000 | +55.8% | 11,834,595 | 0.0% | 2.82% | +40.5% | |
AAVL | Buy | AVALANCHE BIOTECHNOLOGIES IN | $85,800,000 | -1.6% | 2,117,473 | +31.1% | 2.78% | -11.3% |
Sell | HORIZON PHARMA INCnote 5.000%11/1 | $78,189,000 | -5.2% | 16,014,461 | -49.6% | 2.53% | -14.5% | |
BLUE | Sell | BLUEBIRD BIO INC | $76,243,000 | -2.3% | 631,309 | -25.8% | 2.47% | -11.9% |
FLML | Sell | FLAMEL TECHNOLOGIES SAsponsored adr | $73,229,000 | -18.7% | 4,072,809 | -22.5% | 2.37% | -26.7% |
DVA | Buy | DAVITA HEALTHCARE PARTNERS I | $59,334,000 | +80.1% | 730,000 | +67.8% | 1.92% | +62.3% |
ARRAY BIOPHARMA INCnote 3.000% 6/0 | $56,037,000 | +34.7% | 45,000,000 | 0.0% | 1.82% | +21.4% | ||
INFI | Buy | INFINITY PHARMACEUTICALS INC | $55,475,000 | -14.9% | 3,968,155 | +2.9% | 1.80% | -23.2% |
UAM | Sell | UNIVERSAL AMERN CORP NEW | $55,388,000 | +6.3% | 5,186,148 | -7.6% | 1.79% | -4.2% |
INTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1 | $54,556,000 | +8.2% | 47,428,000 | 0.0% | 1.77% | -2.5% | ||
ONCE | New | SPARK THERAPEUTICS INC | $48,917,000 | – | 631,192 | +100.0% | 1.58% | – |
WBA | New | WALGREENS BOOTS ALLIANCE INC | $43,424,000 | – | 512,800 | +100.0% | 1.41% | – |
ZFGN | New | ZAFGEN INC | $41,598,000 | – | 1,050,178 | +100.0% | 1.35% | – |
ARNA | Buy | ARENA PHARMACEUTICALS INC | $40,332,000 | +67.2% | 9,229,379 | +32.7% | 1.31% | +50.6% |
GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $40,297,000 | +67.4% | 873,185 | +55.0% | 1.30% | +50.9% |
ELGX | Sell | ENDOLOGIX INC | $40,103,000 | -22.4% | 2,349,351 | -30.5% | 1.30% | -30.0% |
VNDA | Sell | VANDA PHARMACEUTICALS INC | $38,448,000 | -35.1% | 4,134,157 | -0.1% | 1.24% | -41.5% |
ENDOLOGIX INCnote 2.250%12/1 | $35,203,000 | +1.9% | 34,925,000 | 0.0% | 1.14% | -8.2% | ||
INSM | Sell | INSMED INC | $33,873,000 | -2.3% | 1,628,531 | -27.4% | 1.10% | -12.0% |
GWPH | New | GW PHARMACEUTICALS PLCads | $33,144,000 | – | 363,700 | +100.0% | 1.07% | – |
ATRS | Buy | ANTARES PHARMA INC | $32,732,000 | +57.2% | 12,078,318 | +49.0% | 1.06% | +41.7% |
EHTH | Buy | EHEALTH INC | $30,622,000 | -45.7% | 3,264,588 | +44.2% | 0.99% | -51.1% |
AET | New | AETNA INC NEW | $30,286,000 | – | 284,300 | +100.0% | 0.98% | – |
SAGE | Buy | SAGE THERAPEUTICS INC | $29,909,000 | +211.2% | 595,443 | +126.7% | 0.97% | +180.9% |
XNCR | New | XENCOR INC | $29,040,000 | – | 1,895,535 | +100.0% | 0.94% | – |
ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $27,708,000 | -22.5% | 2,810,164 | -3.8% | 0.90% | -30.2% |
ACCURAY INCnote 3.750% 8/0 | $26,694,000 | +6.8% | 24,100,000 | 0.0% | 0.86% | -3.7% | ||
Buy | WEBMD HEALTH CORPnote 1.500%12/0 | $24,433,000 | +44.4% | 23,000,000 | +35.3% | 0.79% | +30.1% | |
HEARTWARE INTL INCnote 3.500%12/1 | $23,227,000 | +6.7% | 20,464,000 | 0.0% | 0.75% | -3.8% | ||
CRL | New | CHARLES RIV LABS INTL INC | $22,950,000 | – | 289,450 | +100.0% | 0.74% | – |
OFIX | Buy | ORTHOFIX INTL N V | $22,619,000 | +41.0% | 630,222 | +18.1% | 0.73% | +27.3% |
ALIM | Buy | ALIMERA SCIENCES INC | $22,147,000 | -1.2% | 4,420,580 | +9.3% | 0.72% | -10.9% |
PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $21,810,000 | +17.5% | 574,546 | -12.4% | 0.71% | +5.8% |
MCK | MCKESSON CORP | $20,810,000 | +9.0% | 92,000 | 0.0% | 0.67% | -1.7% | |
LOXO | LOXO ONCOLOGY INC | $19,815,000 | +6.0% | 1,591,546 | 0.0% | 0.64% | -4.5% | |
GILD | GILEAD SCIENCES INCput | $19,626,000 | +4.1% | 200,000 | 0.0% | 0.64% | -6.1% | |
INGN | Buy | INOGEN INC | $19,251,000 | +73.2% | 601,772 | +69.8% | 0.62% | +56.4% |
AERI | Sell | AERIE PHARMACEUTICALS INC | $18,996,000 | -65.0% | 606,118 | -67.4% | 0.62% | -68.4% |
DYAX | Buy | DYAX CORP | $18,957,000 | +37.2% | 1,131,414 | +15.1% | 0.61% | +23.8% |
HUM | New | HUMANA INC | $18,924,000 | – | 106,300 | +100.0% | 0.61% | – |
PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $17,802,000 | -55.7% | 3,048,310 | -40.5% | 0.58% | -60.0% |
TRUP | Sell | TRUPANION INC | $16,815,000 | -9.4% | 2,101,848 | -21.5% | 0.54% | -18.3% |
NUVA | New | NUVASIVE INC | $15,554,000 | – | 338,194 | +100.0% | 0.50% | – |
ANTM | New | ANTHEM INC | $15,401,000 | – | 99,742 | +100.0% | 0.50% | – |
NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $14,884,000 | +15.7% | 1,460,652 | +58.2% | 0.48% | +4.3% |
PRTO | PROTEON THERAPEUTICS INC | $14,716,000 | +11.8% | 1,265,343 | 0.0% | 0.48% | +0.8% | |
IMPR | Buy | IMPRIVATA INC | $14,359,000 | +10.6% | 1,025,652 | +2.7% | 0.46% | -0.2% |
OVAS | Sell | OVASCIENCE INC | $14,139,000 | -49.0% | 407,108 | -35.1% | 0.46% | -54.0% |
AACH | New | AAC HLDGS INC | $13,649,000 | – | 446,328 | +100.0% | 0.44% | – |
AXGN | Buy | AXOGEN INC | $13,548,000 | +150.3% | 3,870,824 | +156.7% | 0.44% | +126.3% |
TXMD | New | THERAPEUTICSMD INC | $13,451,000 | – | 2,223,310 | +100.0% | 0.44% | – |
JUNO | Sell | JUNO THERAPEUTICS INC | $11,110,000 | -40.6% | 183,149 | -48.9% | 0.36% | -46.4% |
STDY | New | STEADYMED LTD | $10,776,000 | – | 1,267,733 | +100.0% | 0.35% | – |
FLUIDIGM CORP DELnote 2.750% 2/0 | $10,632,000 | +16.3% | 10,000,000 | 0.0% | 0.34% | +4.6% | ||
TRIV | Sell | TRIVASCULAR TECHNOLOGIES INC | $10,387,000 | -28.1% | 990,202 | -13.8% | 0.34% | -35.3% |
EXEL | New | EXELIXIS INCput | $10,280,000 | – | 4,000,000 | +100.0% | 0.33% | – |
GENN | New | GENESIS HEALTHCARE INC | $10,198,000 | – | 1,432,368 | +100.0% | 0.33% | – |
GNCA | Buy | GENOCEA BIOSCIENCES INC | $10,013,000 | +136.7% | 844,257 | +39.7% | 0.32% | +113.2% |
ADPTQ | Buy | ADEPTUS HEALTH INCcl a | $9,974,000 | +323.0% | 198,600 | +215.0% | 0.32% | +280.0% |
KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $9,744,000 | -41.8% | 765,450 | -35.3% | 0.32% | -47.5% |
IMMU | Sell | IMMUNOMEDICS INC | $9,598,000 | -28.7% | 2,505,972 | -10.7% | 0.31% | -35.7% |
TNXP | New | TONIX PHARMACEUTICALS HLDG C | $8,627,000 | – | 1,365,000 | +100.0% | 0.28% | – |
RIGL | RIGEL PHARMACEUTICALS INC | $8,560,000 | +57.3% | 2,397,855 | 0.0% | 0.28% | +41.3% | |
DSCI | Buy | DERMA SCIENCES INC | $8,394,000 | +24.9% | 991,040 | +37.3% | 0.27% | +12.9% |
ADHD | New | ALCOBRA LTD | $7,956,000 | – | 1,413,208 | +100.0% | 0.26% | – |
HEALTHWAYS INCnote 1.500% 7/0 | $7,816,000 | -0.2% | 6,700,000 | 0.0% | 0.25% | -10.0% | ||
ELOS | New | SYNERON MEDICAL LTD | $7,745,000 | – | 625,593 | +100.0% | 0.25% | – |
OXFD | New | OXFORD IMMUNOTEC GLOBAL PLC | $7,353,000 | – | 522,250 | +100.0% | 0.24% | – |
ATEC | Buy | ALPHATEC HOLDINGS INC | $7,225,000 | +28.7% | 4,982,738 | +25.1% | 0.23% | +15.8% |
DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $6,964,000 | -46.8% | 298,121 | -38.2% | 0.23% | -51.9% |
TCON | New | TRACON PHARMACEUTICALS INC | $6,809,000 | – | 485,000 | +100.0% | 0.22% | – |
AMPH | Sell | AMPHASTAR PHARMACEUTICALS IN | $6,710,000 | -54.7% | 448,532 | -64.9% | 0.22% | -59.2% |
STRM | STREAMLINE HEALTH SOLUTIONS | $6,471,000 | -18.0% | 1,822,759 | 0.0% | 0.21% | -26.1% | |
FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $6,287,000 | +20.4% | 679,627 | -8.8% | 0.20% | +8.5% |
VSAR | New | VERSARTIS INC | $6,240,000 | – | 339,703 | +100.0% | 0.20% | – |
ZSPH | New | ZS PHARMA INC | $6,202,000 | – | 147,385 | +100.0% | 0.20% | – |
BEAT | Buy | BIOTELEMETRY INC | $5,702,000 | +32.5% | 644,300 | +50.2% | 0.18% | +19.4% |
CLLS | New | CELLECTIS S Asponsored ads | $5,204,000 | – | 150,506 | +100.0% | 0.17% | – |
LMNS | Sell | LUMENIS LTD | $5,202,000 | -6.8% | 434,566 | -27.3% | 0.17% | -16.4% |
CARA | CARA THERAPEUTICS INC | $4,760,000 | +0.8% | 473,588 | 0.0% | 0.15% | -9.4% | |
PRQR | Sell | PROQR THRAPEUTICS N V | $4,582,000 | -44.4% | 209,398 | -44.9% | 0.15% | -50.0% |
New | TRILLIUM THERAPEUTICS INC | $4,573,000 | – | 226,064 | +100.0% | 0.15% | – | |
CDNA | CAREDX INC | $4,458,000 | -23.5% | 804,000 | 0.0% | 0.14% | -31.1% | |
DSCO | DISCOVERY LABORATORIES INC N | $4,355,000 | +2.6% | 3,659,700 | 0.0% | 0.14% | -7.8% | |
CCRN | New | CROSS CTRY HEALTHCARE INC | $4,349,000 | – | 366,724 | +100.0% | 0.14% | – |
CASM | CAS MED SYS INC | $4,272,000 | -19.1% | 3,200,000 | 0.0% | 0.14% | -27.4% | |
SCYX | Sell | SCYNEXIS INC | $4,090,000 | -18.0% | 492,781 | -1.4% | 0.13% | -26.3% |
RTRX | New | RETROPHIN INC | $3,791,000 | – | 158,223 | +100.0% | 0.12% | – |
New | EXELIXIS INCnote 4.250% 8/1 | $3,762,000 | – | 4,985,000 | +100.0% | 0.12% | – | |
DERM | Buy | DERMIRA INC | $3,553,000 | +68.7% | 231,467 | +99.1% | 0.12% | +51.3% |
SCMP | New | SUCAMPO PHARMACEUTICALS INCcl a | $3,501,000 | – | 225,000 | +100.0% | 0.11% | – |
ASND | New | ASCENDIS PHARMA A Ssponsored adr | $3,470,000 | – | 200,000 | +100.0% | 0.11% | – |
STJ | New | ST JUDE MED INC | $3,294,000 | – | 50,370 | +100.0% | 0.11% | – |
NVTA | New | INVITAE CORP | $2,793,000 | – | 166,666 | +100.0% | 0.09% | – |
PTN | PALATIN TECHNOLOGIES INC | $2,040,000 | +39.7% | 2,000,000 | 0.0% | 0.07% | +26.9% | |
KIN | Sell | KINDRED BIOSCIENCES INC | $1,994,000 | -24.0% | 279,204 | -20.8% | 0.06% | -30.9% |
IMMU | IMMUNOMEDICS INCcall | $1,915,000 | -20.2% | 500,000 | 0.0% | 0.06% | -27.9% | |
BVX | New | BOVIE MEDICAL CORP | $1,673,000 | – | 700,000 | +100.0% | 0.05% | – |
ACAD | New | ACADIA PHARMACEUTICALS INC | $1,610,000 | – | 49,400 | +100.0% | 0.05% | – |
MEIP | Sell | MEI PHARMA INC | $1,437,000 | -88.6% | 802,568 | -72.7% | 0.05% | -89.6% |
PARNF | Sell | PARNELL PHARMACEUT HLDGS LTD | $1,245,000 | -20.1% | 253,592 | -32.5% | 0.04% | -28.6% |
ILMN | Buy | ILLUMINA INC | $1,188,000 | +61.0% | 6,400 | +60.0% | 0.04% | +40.7% |
PTBI | Sell | PLASMATECH BIOPHARMACEUTICAL | $1,099,000 | -14.5% | 349,908 | -6.0% | 0.04% | -21.7% |
ALKS | New | ALKERMES PLC | $1,067,000 | – | 17,500 | +100.0% | 0.04% | – |
New | CORSICANTO LTDnote 3.500% 1/1 | $1,044,000 | – | 1,000,000 | +100.0% | 0.03% | – | |
AGRX | AGILE THERAPEUTICS INC | $973,000 | +50.9% | 105,000 | 0.0% | 0.03% | +39.1% | |
MRTX | New | MIRATI THERAPEUTICS INC | $965,000 | – | 32,912 | +100.0% | 0.03% | – |
ABT | New | ABBOTT LABS | $602,000 | – | 13,000 | +100.0% | 0.02% | – |
MYL | New | MYLAN N V | $594,000 | – | 10,000 | +100.0% | 0.02% | – |
NKTR | New | NEKTAR THERAPEUTICS | $502,000 | – | 45,600 | +100.0% | 0.02% | – |
AEZS | New | AETERNA ZENTARIS INC | $482,000 | – | 898,574 | +100.0% | 0.02% | – |
RAD | New | RITE AID CORP | $459,000 | – | 52,764 | +100.0% | 0.02% | – |
MZOR | New | MAZOR ROBOTICS LTDsponsored ads | $470,000 | – | 41,861 | +100.0% | 0.02% | – |
HMSY | New | HMS HLDGS CORP | $462,000 | – | 29,900 | +100.0% | 0.02% | – |
CELG | New | CELGENE CORP | $403,000 | – | 3,500 | +100.0% | 0.01% | – |
PTBIW | PLASMATECH BIOPHARMACEUTICAL*w exp 10/24/201 | $319,000 | +6.3% | 375,000 | 0.0% | 0.01% | -9.1% | |
ESPR | New | ESPERION THERAPEUTICS INC NE | $232,000 | – | 2,500 | +100.0% | 0.01% | – |
ONTY | Sell | ONCOTHYREON INC | $233,000 | -69.2% | 143,200 | -64.1% | 0.01% | -70.4% |
IMRSQ | IMRIS INC | $141,000 | +13.7% | 147,076 | 0.0% | 0.01% | +25.0% | |
MSTX | Exit | MAST THERAPEUTICS INC | $0 | – | -700,000 | -100.0% | -0.01% | – |
KND | Exit | KINDRED HEALTHCARE INC | $0 | – | -37,611 | -100.0% | -0.02% | – |
ZTS | Exit | ZOETIS INCcl a | $0 | – | -25,097 | -100.0% | -0.04% | – |
EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -10,000 | -100.0% | -0.05% | – |
SLXP | Exit | SALIX PHARMACEUTICALS INC | $0 | – | -11,500 | -100.0% | -0.05% | – |
EXEL | Exit | EXELIXIS INCcall | $0 | – | -1,000,000 | -100.0% | -0.05% | – |
FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -99,847 | -100.0% | -0.07% | – |
ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -1,691,857 | -100.0% | -0.10% | – |
OCRX | Exit | OCERA THERAPEUTICS INC | $0 | – | -461,119 | -100.0% | -0.11% | – |
MRGE | Exit | MERGE HEALTHCARE INC | $0 | – | -892,897 | -100.0% | -0.11% | – |
THOR | Exit | THORATEC CORP | $0 | – | -102,919 | -100.0% | -0.12% | – |
KBIO | Exit | KALOBIOS PHARMACEUTICALS INC | $0 | – | -2,286,783 | -100.0% | -0.14% | – |
EGRX | Exit | EAGLE PHARMACEUTICALS INC | $0 | – | -284,653 | -100.0% | -0.16% | – |
PFNX | Exit | PFENEX INC | $0 | – | -625,640 | -100.0% | -0.16% | – |
BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -464,083 | -100.0% | -0.20% | – |
Exit | SPECTRANETICS CORPmtnf 2.625% 6/0 | $0 | – | -5,439,000 | -100.0% | -0.25% | – | |
CNXR | Exit | CONNECTURE INC | $0 | – | -799,750 | -100.0% | -0.26% | – |
TRNX | Exit | TORNIER N V | $0 | – | -288,971 | -100.0% | -0.26% | – |
Exit | ACCURAY INCnote 3.500% 2/0 | $0 | – | -5,000,000 | -100.0% | -0.27% | – | |
KITE | Exit | KITE PHARMA INC | $0 | – | -155,799 | -100.0% | -0.32% | – |
ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -60,393 | -100.0% | -0.34% | – |
HTWR | Exit | HEARTWARE INTL INC | $0 | – | -164,800 | -100.0% | -0.44% | – |
ARAY | Exit | ACCURAY INC | $0 | – | -1,870,943 | -100.0% | -0.51% | – |
RMD | Exit | RESMED INC | $0 | – | -296,300 | -100.0% | -0.60% | – |
CBST | Exit | CUBIST PHARMACEUTICALS INC | $0 | – | -210,200 | -100.0% | -0.76% | – |
Exit | TESARO INCnote 3.000%10/0 | $0 | – | -27,123,000 | -100.0% | -1.22% | – | |
HUM | Exit | HUMANA INCcall | $0 | – | -280,000 | -100.0% | -1.44% | – |
NVRO | Exit | NEVRO CORP | $0 | – | -1,047,093 | -100.0% | -1.46% | – |
AGN | Exit | ALLERGAN INCcall | $0 | – | -200,000 | -100.0% | -1.53% | – |
RNA | Exit | PROSENSA HLDG N V | $0 | – | -3,316,434 | -100.0% | -2.23% | – |
Exit | AMAG PHARMACEUTICALS INCnote 2.500% 2/1 | $0 | – | -45,020,000 | -100.0% | -2.69% | – | |
AGN | Exit | ALLERGAN INC | $0 | – | -606,601 | -100.0% | -4.63% | – |
AUXL | Exit | AUXILIUM PHARMACEUTICALS INC | $0 | – | -6,267,382 | -100.0% | -7.74% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
EHEALTH INC | 25 | Q3 2020 | 2.0% |
INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
MYLAN NV | 23 | Q3 2020 | 6.2% |
PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-03-19 |
4 | 2024-03-19 |
4 | 2024-03-12 |
3 | 2024-03-08 |
4 | 2024-02-16 |
13F-HR | 2024-02-14 |
4 | 2024-02-08 |
3 | 2024-02-01 |
4 | 2023-11-21 |
13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.